ANTEPARTUM HAEMORRHAGE - APH
PLACENTA PRAEVIA
Incidence of antepartum haemorrhage.
Am J
Obstet Gynecol. 1997 Nov;177(5):1071-8.
The association of placenta previa with history of cesarean delivery and
abortion: a metaanalysis.
Department of Obstetrics, Gynecology, and
Reproductive Sciences, University of Medicine and Dentistry of New Jersey,
Robert Wood Johnson Medical School, New Brunswick, USA. Our purpose was to determine the incidence of
placenta previa based on the available epidemiologic evidence and to
quantify the risk of placenta previa based on the presence and number of
cesarean deliveries and a history of spontaneous and induced abortion. STUDY
We reviewed studies on placenta previa published between 1950 and
1996 on the basis of a comprehensive literature search with use of MEDLINE
and by identifying studies cited in the references of published reports.
Studies were chosen for inclusion in the metaanalysis if the incidence of
placenta previa and its cross-classification with either prior cesarean
delivery or abortions (both spontaneous and induced) or both were available.
We also extracted details about the study design (case-control or cohort
study) and place where they were conducted (United States or other
countries). Published case reports dealing with placenta previa and studies
relating to abruptio placentae were excluded from this review. We also
restricted the search to studies published in English. No attempts were made
to locate any unpublished studies. Data from studies identified during the
literature search were reviewed and abstracted by a single author. In case
of discrepancies or when the information presented in a study was unclear,
abstraction by a (blinded) second reviewer was sought to resolve the
discrepancy. Data on the incidence of placenta previa and its
associations with previous cesarean delivery and abortions were abstracted.
Subgroup analyses were performed to identify potential sources of
heterogeneity by study design and place where they were conducted.
Statistical methods used for the metaanalysis included the fixed-effects
logistic regression model, whereas potential sources of heterogeneity among
studies were evaluated by fitting random-effects models. The tabulation of
36 studies identified a total of 3.7 million pregnant women, of whom 13,992
patients were diagnosed with placenta previa. The reported incidence of
placenta previa ranged between 0.28% and 2.0%, or approximately 1 in 200
deliveries. Women with at least one prior cesarean delivery were 2.6 (95%
confidence interval 2.3 to 3.0) times at greater risk for development of
placenta previa in a subsequent pregnancy. The results varied by study
design, with case-control studies showing a stronger relative risk (relative
risk 3.8, 95% confidence interval 2.3 to 6.4) than cohort studies did
(relative risk 2.4, 95% confidence interval 2.1 to 2.8). Four studies,
encompassing 170,640 pregnant women, provided data on the number of previous
cesarean deliveries. These studies showed a dose-response pattern for the
risk of previa on the basis of the number of prior cesarean deliveries.
Relative risks were 4.5 (95% confidence interval 3.6 to 5.5) for one, 7.4
(95% confidence interval 7.1 to 7.7) for two, 6.5 (95% confidence interval
3.6 to 11.6) for three, and 44.9 (95% confidence interval 13.5 to 149.5) for
four or more prior cesarean deliveries. Women with a history of spontaneous
or induced abortion had a relative risk of placenta previa of 1.6 (95%
confidence interval 1.0 to 2.6) and 1.7 (95% confidence interval 1.0 to
2.9), respectively. Substantial heterogeneity in the results of the
metaanalysis was noted among studies. There is a strong
association between having a previous cesarean delivery, spontaneous or
induced abortion, and the subsequent development of placenta previa. The
risk increases with number of prior cesarean deliveries. Pregnant women with
a history of cesarean delivery or abortion must be regarded as high risk for
placenta previa and must be monitored carefully. This study provides yet
another reason for reducing the rate of primary cesarean delivery and for
advocating vaginal birth for women with prior cesarean delivery. PIP: To quantiy
tfhe risk of placenta previa based on
the presence and number of cesarean deliveries and a history of spontaneous
and induced abortion, a meta-analysis was conducted of salient studies
published in the world literature in 1950-96. Subgroup analyses were
conducted to identify important sources of heterogeneity by study design and
location. The tabulation of 36 studies identified a total of 3.7 million
pregnant women, of whom 13,992 had placenta previa. The reported incidence
of placenta previa in these studies ranged from 0.28% to 2.0%. Women with at
least 1 cesarean section delivery were 2.6 times (95% confidence interval
(CI), 2.3-3.0) more likely to develop placenta previa in a subsequent
pregnancy. The relative risk of placenta previa was higher in case-control
studies (3.8) than cohort studies (2.4). An analysis of four studies,
encompassing 170,640 pregnant women, showed a dose-response pattern for the
risk of placenta previa on the basis of the number of previous cesarean
deliveries. The relative risks increased from 4.5 (95% CI, 3.6-5.5) for 1
prior cesarean delivery to 44.9 (95% CI, 13.5-149.5) for 4 or more previous
cesareans. Women with a history of spontaneous abortion had a relative risk
of placenta previa of 1.6 (95% CI, 1.0-2.6), while those with a history of
induced abortion had a relative risk of 1.7 (95% CI, 1.0-2.9). These
findings suggest that pregnant women with a history of cesarean delivery or
abortion should be regarded as at high risk for placenta previa and
monitored closely. They further underscore the importance of avoiding
unnecessary cesarean deliveries and encouraging vaginal birth for women with
prior cesarean delivery.
Thank you for choosing to visit us. This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT. I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.
If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.
Objectives:
Design:
Results:
Conclusion:
Your Own Web Presence
For £35
Have your own web ad on the internet and optimized for good positioning.
Your Own Dedicated Web Page Designed Specifically For You
More Effective
Than Your Own
Single Page Website
For £35












